Latest Financial Results News

Page 20 of 430
Thorney Opportunities Ltd swung to a $4.44 million loss before tax in FY2026, weighed down by unrealised investment losses, yet increased its final dividend and pressed on with share buybacks.
Claire Turing
Claire Turing
31 Aug 2026
Cycliq Group Limited reported a 20.7% revenue decline to AUD 3.79 million for FY2026, but reduced its net loss by 83% to AUD 85,897, driven by disciplined cost control and strategic platform investments.
Sophie Babbage
Sophie Babbage
31 Aug 2026
Osteopore Limited’s half-year results show an 8% revenue drop driven by currency effects, while losses widen 14% as the company invests heavily in product development and market growth.
Ada Torres
Ada Torres
31 Aug 2026
DGL Group's FY26 results show a $5.8 million underlying loss amid investments in manufacturing and logistics capacity, with the company targeting margin improvements through better utilisation and cost control in FY27.
Victor Sage
Victor Sage
31 Aug 2026
Eden Innovations Ltd trimmed its loss to $5 million in FY2026 while erasing bank debt and converting loans into equity, supported by property sales and capital raises.
Maxwell Dee
Maxwell Dee
31 Aug 2026
Pengana International Equities (ASX: PIA) posted a sharp 82% plunge in net profit for FY26, triggering a strategic board reshuffle and a capital management package including a special dividend and buy-back proposal.
Victor Sage
Victor Sage
31 Aug 2026
Peppermint Innovation Limited posted a $2.4 million net loss for FY26 as it shifted from platform development to commercial execution in the Philippines, achieving key regulatory milestones and securing strategic investment.
Claire Turing
Claire Turing
31 Aug 2026
Infotrust Ltd (ASX: ITS) reported a 9.8% rise in FY26 revenue to $64.1 million, powered by a strategic pivot to cyber security. The company exited its Cloud segment, repaid all bank debt, and acquired Catalyst Cyber to boost federal market presence, positioning for profitable growth in FY27.
Sophie Babbage
Sophie Babbage
31 Aug 2026
Invex Therapeutics posted a $1.35 million net loss for FY2026, driven by expanded R&D efforts and a deepening collaboration with Tessara Therapeutics targeting neurological diseases including Alzheimer’s. The company renewed its orphan drug status in Europe and restructured its board during the year.
Ada Torres
Ada Torres
31 Aug 2026
Mayfield Childcare’s HY26 results reveal a 6% revenue decline and deepening statutory loss, offset by operational improvements and strategic restructuring.
Victor Sage
Victor Sage
31 Aug 2026
Adherium's FY2026 results show strong revenue gains from US remote patient monitoring but increased losses due to higher operating costs and commercial expansion.
Ada Torres
Ada Torres
31 Aug 2026
Activeport Group Ltd’s FY26 results show a 36% revenue decline to $6.15 million and a net loss of $14.7 million, driven by strategic shifts towards recurring software revenue and AI infrastructure orchestration. The company launched its own national network in Australia and expanded internationally with new subsidiaries and leadership hires.
Sophie Babbage
Sophie Babbage
31 Aug 2026

Browse the archive

Full archive